Difficulty: Medium
Average Score: 63%
Practice
Following is an MAO-inhibitor and also has anti-tubercular activity
Correct answer
A
Rationale
In the context of pharmacology of CNS drugs, understanding the mechanism of action of MAO inhibitors is crucial. Iproniazid is the correct answer in this case because it is not only an MAO inhibitor but also possesses anti-tubercular activity. Iproniazid works by irreversibly inhibiting monoamine oxidase, an enzyme responsible for breaking down neurotransmitters like serotonin, dopamine, and norepinephrine in the brain, hence increasing their levels to alleviate symptoms of depression.
Phenelzine and Isocarboxazid are also MAO inhibitors but do not possess anti-tubercular activity, making them incorrect options in this scenario. Moclobemide, on the other hand, is a reversible MAO-A inhibitor used for treating depression and social anxiety disorder but does not have anti-tubercular properties like Iproniazid.
In an educational context, this question helps reinforce the importance of understanding the dual pharmacological actions of certain drugs and highlights the diverse therapeutic uses of MAO inhibitors beyond their primary indication for treating depression. It also underscores the significance of precision and attention to detail in pharmacological knowledge to differentiate between similar drug classes.
Phenelzine and Isocarboxazid are also MAO inhibitors but do not possess anti-tubercular activity, making them incorrect options in this scenario. Moclobemide, on the other hand, is a reversible MAO-A inhibitor used for treating depression and social anxiety disorder but does not have anti-tubercular properties like Iproniazid.
In an educational context, this question helps reinforce the importance of understanding the dual pharmacological actions of certain drugs and highlights the diverse therapeutic uses of MAO inhibitors beyond their primary indication for treating depression. It also underscores the significance of precision and attention to detail in pharmacological knowledge to differentiate between similar drug classes.